4 Merger and Acquisitions Stock Stories Making a Buzz Today

New York Times Co. (NYSE:NYT): Current price $10.85

New York Times Co. might well get a price for The Boston Globe around one-tenth of what it paid in 1993, which would indicate the industry’s sharp slide over the past two decades. Knowledgeable sources say that the bids are could come in the range of $100 million. Potential suitors include the former Globe President Rick Daniels, and the former Time Inc. Chief Executive Jack Griffin, in partnership with the cousins Steven and Ben Taylor, whose family once owned the newspaper.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

NYT

Merck & Co. (NYSE:MRK): Current price $47.13

On Thursday, the South African based-Aspen Pharmacare said that it will purchase drugs and a factory from Merck in a $1-billion deal that reinforces its footprint in Europe, Latin America and Asia. Africa’s largest generic drugs manufacturer said that it would buy an active pharmaceutical ingredient unit located in the Netherlands, along with a portfolio of 11 drug brands from Merck. However, Aspen reported that the deal is subject to the approval of various competition authorities and also the South African Reserve Bank.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

MRK

Amgen (NASDAQ:AMGN): Current price $96.42

The planet’s biggest biotech firm, Amgen, is one of three remaining bidders for Biocad, a Russian biotech company which is attempting to copy some of the top-selling cancer medicines in the world, according to two inside sources, who added that Biocad could be valued at up to $1 billion. At the same time, a second person calculated its value at nearer $750 million. Pfizer is said by the sources to be one of the other bidders; both it and Amgen are developing so-called biosimilars, which are of course copies of branded biological drugs.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

AMGN

The Hartford Financial Services Group (NYSE:HIG): Current price $31.04

Hartford will divest its subsidiary, Hartford Life International Limited, in a cash transaction to the Berkshire Hathaway company Columbia Insurance Company for around $285 million. Upon the close, Hartford Life’s remaining asset will be its subsidiary, Hartford Life Limited, a company based in Dublin that sold variable annuities in the United Kingdom from 2005 to 2009.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

HIG

Don’t Miss: Can Toyota Do for Hydrogen What Tesla Did for the EV?